Target Has Further Runway, Analysts Say -- Market Talk
Dow Jones2026/08/19 23:061906 ET - Target has made progress in its turnaround so far, and has more runway ahead to improve its results, D.A. Davidson analysts say in a note. The company is blending the "art" and the "science" of retailing, returning to a merchandise-led organization to make it a shopping destination once again as it also improves its inventory management, supply chain, in-store execution and delivery strength, the analysts say. That's led to two consecutive quarters of solid comparable sales, they say. "We think there is plenty of room to go, both on the sales and profit, yielding higher earnings power," they say, raising their price target on the stock to $185 from $170. (kelly.cloonan@wsj.com)
(END) Dow Jones Newswires
August 19, 2026 19:06 ET (23:06 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Pfizer (PFE.US) overseas price increase gains to be shared with the U.S. government: "Most Favored Nation" contract revealed, over twenty transactions still confidential
According to reports, under a new contract with the U.S. Department of Health and Human Services, Pfizer will share higher overseas drug revenues with the United States.
Autoimmune and inflammatory disease pharmaceutical company TRex Bio (TRX.US) applies for US listing, plans to raise up to 100 millions dollars.
TRex Bio filed documents with the U.S. Securities and Exchange Commission (SEC) last Friday, intending to raise up to 100 million USD through an initial public offering (IPO).
Sui crypto surges 14% – Why traders must watch $1.05 closely
Crypto prices
More
